Global venture and growth investor founded in 2014, managing over USD 2bn with a focus on biotechnology and enterprise core technology; Chinese name Heyu Capital.
Type: vc | Headquarters: China | AUM: USD 2000000000 (2026) | Portfolio Companies: 5